Average Co-Inventor Count = 5.71
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (24 from 2,078 patents)
2. Astex Therapeutics Limited (5 from 123 patents)
3. Janssen-cilag S.a. (1 from 2 patents)
4. Marc Gaston Venet (0 patent)
5. Patrick Rene Angibaud (0 patent)
6. Philippe Muller (0 patent)
7. Gerard Charles Sanz (0 patent)
8. Virginie Sophie Poncelet (0 patent)
9. Yannick Aime Eddy Ligny (0 patent)
30 patents:
1. 12084462 - Spiro bicyclic inhibitors of menin-MLL interaction
2. 11542247 - Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancer
3. 11530226 - Azepane inhibitors of menin-MLL interaction
4. 11267804 - (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity
5. 11220517 - Spiro bicyclic inhibitors of menin-MLL interaction
6. 11155555 - Compounds
7. 10975100 - Fused bicyclic inhibitors of menin-MLL interaction
8. 10894793 - Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors
9. 10611778 - Fused bicyclic inhibitors of menin-MLL interaction
10. 10526316 - Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors
11. 10202387 - Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors
12. 10087187 - Imidazopyridazine derivatives as PI3KB inhibitors
13. 10045982 - Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
14. 9636341 - Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
15. 9598396 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors